Growth Metrics

Welsis (WLSS) Debt Ratio (2021 - 2024)

Welsis' quarterly Debt Ratio came in at 2.31 in Q2 2024, up 76.17% year-on-year from 1.31 in Q3 2023, and up 11.54% quarter-over-quarter from 2.07 in Q1 2024.

Welsis has reported Debt Ratio for 4 years, with the latest figure at 2.31 in Q2 2024.

  • For the quarter ending Q2 2024, Debt Ratio rose 76.17% year-over-year to 2.31; the trailing twelve-month figure through Jun 2024 stood at 2.31 (up 76.17% YoY), and the FY2023 full-year result was 1.21, up 50.86% from the prior year.
  • Debt Ratio for Q2 2024 stood at 2.31, up from 2.07 in the prior quarter.
  • The five-year high for Debt Ratio was 2.31 in Q2 2024, with the low at 0.8 in Q3 2022.
  • Average Debt Ratio over 4 years is 1.35, with a median of 1.21 recorded in 2023.
  • Year-over-year, Debt Ratio declined 21.39% in 2022 and jumped 92.17% in 2023.
  • Tracing WLSS's Debt Ratio over 4 years: stood at 1.02 in 2021, then declined by 9.84% to 0.92 in 2022, then soared by 92.17% to 1.76 in 2023, then surged by 30.97% to 2.31 in 2024.
  • The last three Debt Ratio figures came in at 2.31 (Q2 2024), 2.07 (Q1 2024), and 1.76 (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn -
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn 0.40
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn 0.29
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn -
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn -
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn 0.25
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn -
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn -
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn -
10 Welsis - - - -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2024 2.31
Mar 31, 2024 2.07
Dec 31, 2023 1.76
Sep 30, 2023 1.21
Jun 30, 2023 1.31
Mar 31, 2023 1.41
Dec 31, 2022 0.92
Sep 30, 2022 0.80
Jun 30, 2022 1.03
Mar 31, 2022 1.05
Sep 30, 2021 1.02